Metamodeling of late rectal bleeding in patients undergoing radiotherapy for prostate cancer.

Published on Feb 26, 2018in Journal of Clinical Oncology32.956
· DOI :10.1200/JCO.2018.36.6_SUPPL.61
Alessandro Cicchetti7
Estimated H-index: 7
,
Federica Palorini11
Estimated H-index: 11
+ 14 AuthorsRiccardo Valdagni51
Estimated H-index: 51
Sources
Abstract
61Background: Predictive models for late rectal bleeding (LRB) after radiotherapy (RT) for prostate cancer were established by several studies, with good performance on development population (POP). Nonetheless, they were found to be unsatisfactory in their generalization to independent validation cohorts. Aim of the study is to build a metamodel for grade 2-3 (G23) and grade 3 (G3) LRB (LENT/SOMA) starting from literature evidence and to validate it on a new POP. Methods: The metamodel was constituted by clinical/dosimetric features and by their coefficients. Available predictive models for LRB were selected by literature search. Models including rectal Equivalent Uniform Dose (EUD) with/without patient-related dose-modifying factors were retrieved. The process allowed identification of “evidence-based” clinical/dosimetric features associated to LRB. Coeff. for identified features were resolved by weighted mean of published values, using their standard deviation as weight and then inserted in a sigmoid-s...
📖 Papers frequently viewed together
2015EMBC: International Conference of the IEEE Engineering in Medicine and Biology Society
2 Citations
References0
Newest
Cited By1
Newest
#2N. Ghadlyalpatil (Yashoda Hospitals)
Last. Purvish M. ParikhH-Index: 23
view all 9 authors...
Esophageal cancer continues to remain a global problem. The majority of patients with advanced and/or metastatic disease will have limited survival, which has essentially remained unchanged over the past 20 years. The dawn of the immunotherapy resurgence has brought hope in the lives of many patients with lung cancer and other solid tumors. The emerging data for esophageal cancer also indicates benefit in selected patients. We summarize the current data available in this review.
Source